Impaired unfolded protein response, BDNF and synuclein markers in postmortem dorsolateral prefrontal cortex and caudate nucleus of patients with depression and Parkinson's disease
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Journal Year:
2025,
Volume and Issue:
138, P. 111299 - 111299
Published: Feb. 25, 2025
Language: Английский
Multi-scale Neural Homeostasis Mechanisms: Insights into Neurodegenerative Diseases and Therapeutic Approaches, Including Exercise
Advanced Exercise and Health Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 1, 2025
Language: Английский
The Role of Microglia and Astrocytes in the Pathomechanism of Neuroinflammation in Parkinson’s Disease—Focus on Alpha-Synuclein
Journal of Integrative Neuroscience,
Journal Year:
2024,
Volume and Issue:
23(11)
Published: Nov. 15, 2024
Glial
cells,
including
astrocytes
and
microglia,
are
pivotal
in
maintaining
central
nervous
system
(CNS)
homeostasis
responding
to
pathological
insults.
This
review
elucidates
the
complex
immunomodulatory
functions
of
glial
with
a
particular
focus
on
their
involvement
inflammation
cascades
initiated
by
accumulation
alpha-synuclein
(α-syn),
hallmark
Parkinson’s
disease
(PD).
Deriving
insights
from
studies
both
sporadic
familial
forms
PD,
as
well
animal
models
we
explore
how
cells
contribute
progression
triggered
α-syn
aggregation.
Additionally,
analyze
interplay
between
blood-brain
barrier
(BBB),
highlighting
role
these
BBB
integrity
permeability
context
PD
pathology.
Furthermore,
delve
into
potential
activation
repair
neuroprotective
mechanisms
mediated
amidst
α-syn-induced
neuroinflammation.
By
integrating
information
dynamics,
this
aims
deepen
our
understanding
multifaceted
interactions
pathology,
CNS
inflammation,
thereby
offering
valuable
therapeutic
strategies
for
related
neurodegenerative
disorders.
Language: Английский
The Interplay of Stress, Inflammation, and Metabolic Factors in the Course of Parkinson’s Disease
Tracey Shaul,
No information about this author
Dan Frenkel,
No information about this author
Tanya Gurevich
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(22), P. 12409 - 12409
Published: Nov. 19, 2024
Parkinson's
disease
(PD)
is
a
prevalent
neurodegenerative
condition
for
which
there
are
symptomatic
treatments
but
no
disease-modifying
therapies
(DMTs).
Extensive
research
over
the
years
has
highlighted
need
multi-target
DMT
approach
in
PD
that
recognizes
various
risk
factors
and
their
intricate
interplay
contributing
to
PD-related
neurodegeneration.
Widespread
factors,
such
as
emotional
stress
metabolic
have
increasingly
become
focal
points
of
exploration.
Our
review
aims
summarize
interactions
between
selected
key
players
metabolism,
insulin,
potential
mechanisms
underlying
neurodegeneration
PD.
Language: Английский